Mark Zylka, PhD and his team at UNC School of Medicine have been studying CRISPR-Cas9 as a method to unsilence the paternal copy of UBE3A. After ASF funded the project, the findings were so positive, the NIH provided additional funding of […]
Read more
On July 23, 2020, Ovid Therapeutics announced a research collaboration with UCONN Health and Stormy Chamberlain, PhD. This exciting work began as an innovative idea funded by the Angelman Syndrome Foundation. Short hairpin RNA (shRNAs) work like ASOs, but can be […]
Read more
Deerfield and Pinnacle Hill have partnered with Dr, Ben Philpot, UNC Chapel Hill, to advance a new therapeutic for AS! Their work focuses on manipulating gene expression and this collaboration will accelerate work previously funded by the ASF to the […]
Read more
ASF Funded Research leads to a collaboration for gene therapy to correct deficiency in UBE3A gene Asklepios BioPharmaceutical, Inc. (AskBio), a leading clinical-stage adeno-associated virus (AAV) gene therapy company, entered into a research collaboration and licensing agreement with the […]
Read more
A UNC Healthcare announced on September 17, 2019: The National Institutes of Health have awarded two separate grants totaling $6.1 million to Mark Zylka, PhD, director of the UNC Neuroscience Center.at the UNC School of Medicine. One of these projects […]
Read more
Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 for the Treatment of Angelman Syndrome at the 65th AACAP Annual Meeting […]
Read more
The First Comprehensive Clinic in Illinois Providing Support for Individuals with Angelman Syndrome (CHICAGO) – Rush University Medical Center and the Angelman Syndrome Foundation (ASF), a national nonprofit organization headquartered in Aurora, Ill., announced the official opening of the Angelman […]
Read more
The ASF Celebrates the Opening of the New Angelman Syndrome Clinic at Mayo Clinic One-Stop Facility Provides Comprehensive Support for Individuals with Angelman syndrome from Infancy through Adulthood ROCHESTER, Minn., November 30, 2015 – Mayo Clinic and the Angelman Syndrome Foundation […]
Read more